Relugolix Completed Phase 1 Trials for Japanese Premenopausal Healthy Adult Women Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02792062A Food Effect Study of TAK-385 Final Formulation